# Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

> **NCT05298033** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 32 (actual)

## Conditions studied

- Vitiligo

## Interventions

- **DRUG:** Crisaborole 2 % Topical Ointment
- **DRUG:** PF-07038124 0.01% topical ointment
- **DEVICE:** NBUVB phototherapy
- **DEVICE:** Sham phototherapy
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT05298033
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-07
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05298033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05298033, "Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05298033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*